Skip to main navigation Skip to search Skip to main content

Does concurrent pharmacotherapy enhance behavioral interventions for mild cognitive impairment? Evidence from the HABIT program

  • Zhigang Xie
  • , Dona Locke
  • , Anni Shandera-Ochsner
  • , Hanadi Hamadi
  • , Liselotte De Wit
  • , Octavio Santos
  • , Elizabeth A. Boots
  • , Stephanie Aghamoosa
  • , Jeremy Grant
  • , Glenn Smith
  • , Melanie Chandler
  • University of Florida
  • Emory University School of Medicine
  • Mayo Clinic
  • Ohio State University
  • Center for the Science of Health Care Delivery

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)959-968
Number of pages10
JournalJournal of Alzheimer's Disease
Volume113
Issue number2
DOIs
StatePublished - Sep 2026

ASJC Scopus Subject Areas

  • General Neuroscience
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Keywords

  • Alzheimer's disease
  • clinical outcome
  • mild cognitive impairment
  • multicomponent behavioral intervention
  • pharmacological therapies

Fingerprint

Dive into the research topics of 'Does concurrent pharmacotherapy enhance behavioral interventions for mild cognitive impairment? Evidence from the HABIT program'. Together they form a unique fingerprint.

Cite this